跳至主要内容
临床试验/NL-OMON53177
NL-OMON53177招募中不适用

Evaluating the effect of Agaricus bisporus powder intake on the vaccination response to an influenza vaccine - Agaricus bisporus and influenza vaccination response

niversiteit Maastricht0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Aged 60 years or older during influenza season 2023/2024 (in line with RIVM
  • guidelines)
  • BMI between 20 and 35 kg/m2
  • Willing to abstain from mushrooms other than the capsules containing a mushroom
  • powder as provided by us during the study period.
  • Willing to keep the intake of fish oil, Zinc, Selenium and (vitamin)
  • supplements constant
  • Willing to abstain from products / supplements enriched with Vitamin D
  • Willing to abstain from products / supplements enriched with plant sterols or
  • Willing to abstain from products / supplements enriched with (β)glucans or
  • Willing to abstain from products / supplements that are mentioned to *boost
  • your immune system*
  • Willing to abstain from (products enriched in) pre/pro-biotics

排除标准

  • Already received influenza vaccination in 2023
  • Allergy to mushrooms
  • Known allergic reaction to an active component or other components of the
  • vaccine (e.g. Chicken Eggs)
  • Having donated blood within one month prior to the start of the study, or
  • planning to donate blood during the study
  • Excessive alcohol use (>20 consumptions per week)
  • Regular use of soft and/or hard drugs
  • Using medication for diseases known to affect inflammation/immunity (e.g.
  • inhaled corticosteroids and prednisone)

研究者

相似试验